Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2Silvan Francke,Anna Mies,Manja Meggendorfer,Uta Oelschlaegel,Ekaterina Balaian,Silke Gloaguen,Torsten Haferlach,Gerhard Ehninger,Martin Bornhäuser,Uwe PlatzbeckerLEUKEMIA & LYMPHOMA(2017)引用 2|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要